Phage display as a promising approach for vaccine development L Aghebati-Maleki, B Bakhshinejad, B Baradaran, M Motallebnezhad, ... Journal of biomedical science 23, 1-18, 2016 | 224 | 2016 |
The immunobiology of myeloid-derived suppressor cells in cancer M Motallebnezhad, F Jadidi-Niaragh, ES Qamsari, S Bagheri, T Gharibi, ... Tumor Biology 37, 1387-1406, 2016 | 96 | 2016 |
Biological effects of IL-21 on different immune cells and its role in autoimmune diseases T Gharibi, J Majidi, T Kazemi, R Dehghanzadeh, M Motallebnezhad, ... Immunobiology 221 (2), 357-367, 2016 | 90 | 2016 |
Targeting autophagy in cardiac ischemia/reperfusion injury: a novel therapeutic strategy M Aghaei, M Motallebnezhad, S Ghorghanlu, A Jabbari, A Enayati, ... Journal of Cellular Physiology 234 (10), 16768-16778, 2019 | 88 | 2019 |
The role of IL17B-IL17RB signaling pathway in breast cancer V Alinejad, S Dolati, M Motallebnezhad, M Yousefi Biomedicine & Pharmacotherapy 88, 795-803, 2017 | 76 | 2017 |
Association between vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis D Imani, B Razi, M Motallebnezhad, R Rezaei BMC neurology 19, 1-17, 2019 | 65 | 2019 |
The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies M Motallebnezhad, L Aghebati-Maleki, F Jadidi-Niaragh, H Nickho, ... Tumor Biology 37, 11711-11721, 2016 | 57 | 2016 |
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis E Safarzadeh, F Jadidi-Niaragh, M Motallebnezhad, M Yousefi Inflammation Research 65, 511-520, 2016 | 56 | 2016 |
Vitamin D receptor gene polymorphism and susceptibility to asthma: meta-analysis based on 17 case-control studies MH Makoui, D Imani, M Motallebnezhad, M Azimi, B Razi Annals of Allergy, Asthma & Immunology 124 (1), 57-69, 2020 | 47 | 2020 |
Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives E Safari, S Ghorghanlu, H Ahmadi‐khiavi, S Mehranfar, R Rezaei, ... Journal of Cellular Physiology 234 (7), 9966-9981, 2019 | 45 | 2019 |
Implications the Role of miR-155 in the Pathogenesis of Autoimmune Diseases S Pashangzadeh, M Motallebnezhad, F Vafashoar, A Khalvandi, ... Frontiers in immunology 12, 669382, 2021 | 41 | 2021 |
Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: non randomized, open-label clinical trial M Ahmadi, M Nouri, Z Babaloo, L Farzadi, A Ghasemzadeh, K Hamdi, ... Immunology letters 192, 12-19, 2017 | 41 | 2017 |
Immune checkpoints and cancer development: Therapeutic implications and future directions S Mehdizadeh, H Bayatipoor, S Pashangzadeh, R Jafarpour, Z Shojaei, ... Pathology-Research and Practice 223, 153485, 2021 | 37 | 2021 |
IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression T Gharibi, A Hosseini, F Marofi, M Oraei, S Jahandideh, ... Immunology letters 216, 12-20, 2019 | 36 | 2019 |
Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia L Aghebati-Maleki, M Shabani, B Baradaran, M Motallebnezhad, J Majidi, ... Biomedicine & Pharmacotherapy 88, 814-822, 2017 | 32 | 2017 |
Current approaches for the treatment of male infertility with stem cell therapy Z Pourmoghadam, L Aghebati‐Maleki, M Motallebnezhad, B Yousefi, ... Journal of cellular physiology, 2018 | 26 | 2018 |
Vitamin D receptor (VDR) gene polymorphisms and risk of coronary artery disease (CAD): systematic review and meta-analysis S Tabaei, M Motallebnezhad, SS Tabaee Biochemical Genetics 59, 813-836, 2021 | 24 | 2021 |
Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor H Nickho, V Younesi, L Aghebati-Maleki, M Motallebnezhad, ... Bioengineered 8 (5), 501-510, 2017 | 22 | 2017 |
Early stage evaluation of colon cancer using tungsten disulfide quantum dots and bacteriophage nano-biocomposite as an efficient electrochemical platform R Pourakbari, M Yousefi, B Khalilzadeh, MH Irani-nezhad, A Khataee, ... Cancer Nanotechnology 13 (1), 7, 2022 | 19 | 2022 |
Antiproliferative and apoptotic effects of novel anti-ROR1 single-chain antibodies in hematological malignancies L Aghebati-Maleki, V Younesi, B Baradaran, J Abdolalizadeh, ... SLAS DISCOVERY: Advancing Life Sciences R&D 22 (4), 408-417, 2017 | 19 | 2017 |